Wu J - Search Results

1

Pluripotent stem cell-derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity.

Zhu H, Blum RH, Bjordahl R, Gaidarova S, Rogers P, Lee TT, Abujarour R, Bonello GB, Wu J, Tsai PF, Miller JS, Walcheck B, Valamehr B, Kaufman DS. Zhu H, et al. Among authors: wu j. Blood. 2020 Feb 6;135(6):399-410. doi: 10.1182/blood.2019000621. Blood. 2020. PMID: 31856277 Free PMC article.

2

ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils.

Wang Y, Wu J, Newton R, Bahaie NS, Long C, Walcheck B. Wang Y, et al. Among authors: wu j. Biochim Biophys Acta. 2013 Mar;1833(3):680-5. doi: 10.1016/j.bbamcr.2012.11.027. Epub 2012 Dec 8. Biochim Biophys Acta. 2013. PMID: 23228566 Free PMC article.

3

Identification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cells.

Jing Y, Ni Z, Wu J, Higgins L, Markowski TW, Kaufman DS, Walcheck B. Jing Y, et al. Among authors: wu j. PLoS One. 2015 Mar 27;10(3):e0121788. doi: 10.1371/journal.pone.0121788. eCollection 2015. PLoS One. 2015. PMID: 25816339 Free PMC article.

4

Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells.

Snyder KM, Hullsiek R, Mishra HK, Mendez DC, Li Y, Rogich A, Kaufman DS, Wu J, Walcheck B. Snyder KM, et al. Among authors: wu j. Front Immunol. 2018 Dec 6;9:2873. doi: 10.3389/fimmu.2018.02873. eCollection 2018. Front Immunol. 2018. PMID: 30574146 Free PMC article.

5

Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy.

Wu J, Mishra HK, Walcheck B. Wu J, et al. J Leukoc Biol. 2019 Jun;105(6):1297-1303. doi: 10.1002/JLB.2MR1218-501R. Epub 2019 Feb 20. J Leukoc Biol. 2019. PMID: 30786043 Free PMC article. Review.

6

iNK-CD64/16A cells: a promising approach for ADCC?

Walcheck B, Wu J. Walcheck B, et al. Among authors: wu j. Expert Opin Biol Ther. 2019 Dec;19(12):1229-1232. doi: 10.1080/14712598.2019.1667974. Epub 2019 Sep 19. Expert Opin Biol Ther. 2019. PMID: 31510805 Free PMC article.

7

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells.

Dixon KJ, Wu J, Walcheck B. Dixon KJ, et al. Among authors: wu j. Cancers (Basel). 2021 Jan 16;13(2):312. doi: 10.3390/cancers13020312. Cancers (Basel). 2021. PMID: 33467027 Free PMC article. Review.

8

Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth.

Hintz HM, Snyder KM, Wu J, Hullsiek R, Dahlvang JD, Hart GT, Walcheck B, LeBeau AM. Hintz HM, et al. Among authors: wu j. Cancer Immunol Res. 2021 Nov;9(11):1270-1282. doi: 10.1158/2326-6066.CIR-21-0178. Epub 2021 Aug 27. Cancer Immunol Res. 2021. PMID: 34452926 Free PMC article.

9

Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells.

Hullsiek R, Li Y, Snyder KM, Wang S, Di D, Borgatti A, Lee C, Moore PF, Zhu C, Fattori C, Modiano JF, Wu J, Walcheck B. Hullsiek R, et al. Among authors: wu j. Front Immunol. 2022 Feb 24;13:841859. doi: 10.3389/fimmu.2022.841859. eCollection 2022. Front Immunol. 2022. PMID: 35281028 Free PMC article.

10

Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production.

Dahlvang JD, Dick JK, Sangala JA, Kennedy PR, Pomeroy EJ, Snyder KM, Moushon JM, Thefaine CE, Wu J, Hamilton SE, Felices M, Miller JS, Walcheck B, Webber BR, Moriarity BS, Hart GT. Dahlvang JD, et al. Among authors: wu j. J Immunol. 2023 Apr 15;210(8):1108-1122. doi: 10.4049/jimmunol.2200488. J Immunol. 2023. PMID: 36881874 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72,016 results

Search Page